TECOGEN INC. Files 8-K for Regulation FD and Exhibits
Ticker: TGEN · Form: 8-K · Filed: Sep 17, 2025 · CIK: 1537435
| Field | Detail |
|---|---|
| Company | Tecogen Inc. (TGEN) |
| Form Type | 8-K |
| Filed Date | Sep 17, 2025 |
| Risk Level | low |
| Pages | 3 |
| Reading Time | 3 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: disclosure, exhibits, regulatory
Related Tickers: TGEN
TL;DR
TECOGEN INC. filed an 8-K on 9/17/25 for Reg FD & exhibits. No major news yet.
AI Summary
On September 17, 2025, TECOGEN INC. filed an 8-K report. The filing primarily concerns Regulation FD Disclosure and Financial Statements and Exhibits. No specific financial figures or material events were detailed in the provided excerpt.
Why It Matters
This 8-K filing indicates that TECOGEN INC. is providing updates related to regulatory disclosures and financial exhibits, which are important for investors to monitor company compliance and financial reporting.
Risk Assessment
Risk Level: low — The filing is a routine 8-K for disclosures and exhibits, with no immediate indication of significant negative events.
Key Players & Entities
- TECOGEN INC. (company) — Registrant
- September 17, 2025 (date) — Date of report
- Delaware (jurisdiction) — State of Incorporation
- 76 Treble Cove Road, Building 1 (address) — Principal Executive Offices
- North Billerica, Massachusetts 01862 (address) — Principal Executive Offices
- 781-466-6400 (phone_number) — Registrant's telephone number
FAQ
What specific information is being disclosed under Regulation FD?
The provided excerpt does not detail the specific information disclosed under Regulation FD, only that it is an item of the 8-K filing.
What financial statements or exhibits are included in this filing?
The excerpt states that 'Financial Statements and Exhibits' are part of the filing, but does not list the specific documents.
When was TECOGEN INC. incorporated?
TECOGEN INC. was incorporated in Delaware, as indicated by the filing.
What is TECOGEN INC.'s principal business address?
TECOGEN INC.'s principal executive offices are located at 76 Treble Cove Road, Building 1, North Billerica, Massachusetts 01862.
What is the filing date of this 8-K report?
The report was filed on September 17, 2025.
Filing Stats: 767 words · 3 min read · ~3 pages · Grade level 13 · Accepted 2025-09-17 09:38:51
Key Financial Figures
- $0.001 — ange on which registered Common Stock, $0.001 par value per share TGEN NYSE American,
Filing Documents
- tgen-20250917.htm (8-K) — 27KB
- faqsabouttecogenchillersfo.htm (EX-99.1) — 29KB
- 0001537435-25-000137.txt ( ) — 164KB
- tgen-20250917.xsd (EX-101.SCH) — 2KB
- tgen-20250917_lab.xml (EX-101.LAB) — 19KB
- tgen-20250917_pre.xml (EX-101.PRE) — 11KB
- tgen-20250917_htm.xml (XML) — 2KB
01. Regulation FD Disclosure
Item 7.01. Regulation FD Disclosure. On September 17, 2025, Tecogen Inc., a Delaware corporation ("Company"), posted on its website at www.Tecogen.com in the section identified as "Investors/Presentations" a document entitled "Frequently Asked Questions - Tecogen Chillers for Artificial (AI) Data Centers," a copy of which is filed as Exhibit 99.1 hereto. The document provides responses to certain questions the Company has received from its stockholders, analysts and others relating to the intended use of Tecogen Chillers for Artificial Intelligence (AI) Data Centers. The information in this Item 7.01 and Exhibit 99.1 to this Current Report on Form 8-K, and information disseminated on the Company's website and on social media websites, shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended ("Securities Exchange Act") , or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Securities Exchange Act, except as expressly set forth by specific reference in such a filing. Disclosure of Important Company Information via Social Media Sites In addition to disclosure included in the Company's periodic reports filed with the Securities and Exchange Commission, including its Current Reports on Form 8-K, the Company has, from time to time, disseminated and expects to continue disseminating certain important information regarding the Company, its business and products on its website at www.Tecogen.com as well as on certain social media websites, including LinkedIn.com and X.com. This may include Company press releases, stockholder letters, and other informational material ("Public Information Releases") . In certain instances, information contained in such Public Information Releases may be deemed "material non-public information" under Federal securities laws, including Regulation FD. Information is cons
01. Financial Statements and Exhibits
Item 9.01. Financial Statements and Exhibits. (d) Exhibits Exhibit Description 99.1 Frequently Asked Questions - C hillers for Artificial Intelligence (AI) Data Centers , filed herewith
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Company has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized. TECOGEN INC. By: /s/ Abinand Rangesh September 17, 2025 Abinand Rangesh, Chief Executive Officer